In this episode of Molecule to Market, we do things a little differently with an experimental episode. You’ll go inside the outsourcing space of the global drug development sector with the best-selling sales author, Ian Altman. 
 
Ian started, sold, and grew his prior companies from zero to over one billion dollars in value. He’s a co-author of the bestseller, Same Side Selling, now in its second edition. He is the author of hundreds of articles on Forbes and Inc. Ian is recognized as one of the world’s Top 30 Global Gurus on Sales, and his Same Side Selling Academy is ranked in the top 5 globally for Sales Development Programs.
 
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Ian Altman discussing “becoming a magnet for your client’s problem” while also making sure the client has a problem worth solving. Ian speaks on the importance of role-playing, practising and rehearsing sales scenarios. He explains the need to aim for the ‘engage’ level with potential clients in order to secure the next pharma or biotech deal. Lastly, Ian explains the importance of understanding your client’s Elevator Rant and the emotion and impact of not solving their issue.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.